Nuclear Mitotic Apparatus Protein 1 (NUMA1) Peptide
Aperçu rapide pour Nuclear Mitotic Apparatus Protein 1 (NUMA1) Peptide (ABIN936841)
Antigène
Origine
Source
Application
-
-
Type de proteíne
- Synthetic
-
Séquence
- AQRLQAQLNE LQAQLSQKEQ AAEHYKLQME KAKTHYDAKK QQNQELQEQL
-
Attributs du produit
-
A synthetic peptide for use as a blocking control in assays to test for specificity of NUMA1 antibody,
Alternative Names: NUMA1 control peptide, NUMA1 antibody Blocking Peptide, Anti-NUMA1 Blocking Peptide, nuclear mitotic apparatus protein 1 Blocking Peptide, NUMA Blocking Peptide, NUMA1, NUMA-1, NUMA 1, NUMA-1 Blocking Peptide, NUMA 1 Blocking Peptide -
Purification
- Immunoaffinity chromatography
-
-
-
-
Indications d'application
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20 °C long term.
-
-
- NUMA1 (Nuclear Mitotic Apparatus Protein 1 (NUMA1))
-
Sujet
- NuMA is a structural element in maintaining nuclear integrity. A critical spindle pole-associated mechanism, called the END (Emi1/NuMA/dynein-dynactin) network, spatially restricts APC/C activity in early mitosis. The entire coding region and exon-intron boundaries of NuMa were screened in 92 familial breast cancer patients. But the results do not support the role of NuMA variants as breast cancer susceptibility alleles.
-
Poids moléculaire
- 238 kDa
Antigène
-